Silence Therapeutics plc
SLN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001479615
No open-market purchases or sales by Silence Therapeutics plc insiders were filed in the last 90 days; 72 institutions reported holding it in 13F filings for Q2 2026, worth $236.2M in total; no superinvestor holds it.
Other share classesSLNCF
13F holders, Q1 2024
Institutional positions in Silence Therapeutics plc as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 64
- +30 vs. Q4 2023
- Shares held
- 27.7M
- +7.18M (+35.0%) vs. Q4 2023
- Total value
- $588.0M
- +$244.1M (+71.0%) vs. Q4 2023
- New holders
- 32
- 17 more added
- Sold out
- 2
- 11 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SLN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 72 | $236.2M |
| Q1 2026 | 56 | $102.1M |
| Q4 2025 | 58 | $106.1M |
| Q3 2025 | 54 | $96.4M |
| Q2 2025 | 55 | $108.0M |
| Q1 2025 | 59 | $60.6M |
| Q4 2024 | 65 | $168.2M |
| Q3 2024 | 69 | $493.1M |
| Q2 2024 | 71 | $502.1M |
| Q1 2024 | 64 | $588.0M |
| Q4 2023 | 34 | $343.9M |
| Q3 2023 | 28 | $187.6M |
| Q2 2023 | 29 | $101.8M |
| Q1 2023 | 29 | $110.2M |
| Q4 2022 | 27 | $275.7M |
| Q3 2022 | 29 | $183.4M |
| Q2 2022 | 25 | $116.4M |
| Q1 2022 | 26 | $218.3M |
| Q4 2021 | 22 | $246.6M |
| Q3 2021 | 7 | $39.4M |
| Q2 2021 | 6 | $56.4M |
| Q1 2021 | 6 | $55.9M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Silence Therapeutics plc; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Rhumbline Advisers | 15 | $324 | 0.00% | +10+200.0% | Added |
| Steward Partners Investment Advisory, LLC | 100 | $2.16K | 0.00% | 00.0% | Unchanged |
| GAMMA Investing LLC | 876 | $18.9K | 0.00% | −42−4.6% | Reduced |
| Advisors Preferred, LLC | 1,109 | $24.1K | 0.00% | +1,109 | New |
| Lazard Asset Management LLC | 1,415 | $29.0K | 0.00% | −855−37.7% | Reduced |
| Qube Research & Technologies Ltd | 3,942 | $85.1K | 0.00% | +3,764+2,114.6% | Added |
| Barclays PLC | 5,570 | $120.3K | 0.00% | +5,570 | New |
| SG Americas Securities, LLC | 7,000 | $151.0K | 0.00% | +667+10.5% | Added |
| Point72 Asset Management, L.P. | 8,200 | $177.1K | 0.00% | +8,200 | New |
| JPMorgan Chase & Co | 9,610 | $207.6K | 0.00% | +9,610 | New |
| Advisor Group Holdings, Inc. | 10,922 | $235.8K | 0.00% | +10,922 | New |
| NEOS Investment Management LLC | 11,656 | $251.8K | 0.02% | +11,656 | New |
| Bank of America Corp | 11,992 | $259.0K | 0.00% | +10,916+1,014.5% | Added |
| Shay Capital LLC | 15,150 | $327.2K | 0.10% | +15,150 | New |
| Jump Financial, LLC | 18,800 | $406.1K | 0.01% | +18,800 | New |
| Rathbone Brothers plc | 19,906 | $430.0K | 0.00% | +19,906 | New |
| Trexquant Investment LP | 21,047 | $454.6K | 0.01% | +21,047 | New |
| Goldman Sachs Group Inc | 21,739 | $469.6K | 0.00% | +21,739 | New |
| Geode Capital Management, LLC | 22,427 | $484.4K | 0.00% | 00.0% | Unchanged |
| Blair William & Co | 25,432 | $549.3K | 0.00% | −116−0.5% | Reduced |
| Cubist Systematic Strategies, LLC | 36,281 | $783.7K | 0.01% | +36,281 | New |
| ADAR1 Capital Management, LLC | 40,090 | $865.9K | 0.24% | +39,900+21,000.0% | Added |
| Citadel Advisors LLC | 42,682 | $921.9K | 0.00% | +20,945+96.4% | Added |
| Artia Global Partners LP | 52,476 | $1.13M | 0.28% | +52,476 | New |
| Citigroup Inc | 58,333 | $1.26M | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 71,918 | $1.55M | 0.00% | +1,972+2.8% | Added |
| UBS Oconnor LLC | 72,223 | $1.56M | 0.04% | −20,975−22.5% | Reduced |
| Two Sigma Advisers, LP | 77,400 | $1.67M | 0.00% | +77,400 | New |
| BIT Capital GmbH | 89,000 | $1.92M | 0.17% | +89,000 | New |
| Walleye Capital LLC | 91,819 | $1.98M | 0.02% | +91,819 | New |
| Cantor Fitzgerald, L. P. | 103,483 | $2.24M | 0.53% | −43,294−29.5% | Reduced |
| Renaissance Technologies LLC | 103,900 | $2.24M | 0.00% | +76,798+283.4% | Added |
| Two Sigma Investments, LP | 107,212 | $2.32M | 0.01% | +107,212 | New |
| Boothbay Fund Management, LLC | 127,224 | $2.75M | 0.08% | +127,224 | New |
| Schonfeld Strategic Advisors LLC | 133,000 | $2.87M | 0.02% | +83,800+170.3% | Added |
| Marshall Wace, LLP | 139,191 | $3.01M | 0.00% | +139,191 | New |
| HSBC Holdings PLC | 177,834 | $3.84M | 0.00% | 00.0% | Unchanged |
| Nantahala Capital Management, LLC | 200,000 | $4.32M | 0.42% | +200,000 | New |
| Woodline Partners LP | 238,380 | $5.15M | 0.05% | +189,108+383.8% | Added |
| Morgan Stanley | 242,770 | $5.24M | 0.00% | +179,962+286.5% | Added |
| Parkman Healthcare Partners LLC | 244,471 | $5.28M | 0.65% | +11,529+4.9% | Added |
| Hudson Bay Capital Management LP | 276,590 | $5.97M | 0.05% | +276,590 | New |
| M28 Capital Management LP | 299,400 | $6.47M | 4.78% | −64,400−17.7% | Reduced |
| Octagon Capital Advisors LP | 315,000 | $6.80M | 0.83% | +315,000 | New |
| Mangrove Partners | 385,408 | $8.32M | 0.72% | +385,408 | New |
| Duquesne Family Office LLCSuperinvestorDuquesne Family Office | 387,400 | $8.37M | 0.22% | +387,400 | New |
| Millennium Management LLC | 409,418 | $8.84M | 0.01% | +409,418 | New |
| 5AM Venture Management, LLC | 476,200 | $10.3M | 2.30% | +476,200 | New |
| Polar Capital Holdings Plc | 500,000 | $10.8M | 0.07% | +500,000 | New |
| Lynx1 Capital Management LP | 526,642 | $11.4M | 2.93% | +290,855+123.4% | Added |
| Aquilo Capital Management, LLC | 574,214 | $12.4M | 9.30% | −469,070−45.0% | Reduced |
| Adage Capital Partners GP, L.L.C. | 600,000 | $13.0M | 0.02% | +600,000 | New |
| Cormorant Asset Management, LP | 625,000 | $13.5M | 0.59% | +625,000 | New |
| Janus Henderson Group PLC | 625,864 | $13.6M | 0.01% | +625,864 | New |
| Nextech Invest AG | 952,400 | $20.6M | 3.26% | +952,400 | New |
| Vivo Capital, LLC | 1,105,454 | $23.9M | 1.88% | +595,250+116.7% | Added |
| Frazier Life Sciences Management, L.P. | 1,148,591 | $24.8M | 1.05% | +267,418+30.3% | Added |
| Logos Global Management LP | 1,476,061 | $31.1M | 3.27% | +1,076,061+269.0% | Added |
| Deep Track Capital, LP | 1,643,881 | $35.5M | 1.02% | −307,699−15.8% | Reduced |
| Lombard Odier Asset Management (USA) Corp | 2,388,912 | $41.6M | 5.99% | −1,490,261−38.4% | Reduced |
| Redmile Group, LLC | 2,027,669 | $43.8M | 1.61% | +2,027,669 | New |
| Lombard Odier Asset Management (Europe) Ltd | 2,238,039 | $48.3M | 3.08% | −1,374,838−38.1% | Reduced |
| Artal Group S.A. | 2,779,619 | $60.0M | 1.55% | −220,381−7.3% | Reduced |
| TCG Crossover Management, LLC | 3,295,350 | $71.2M | 5.63% | +1,190,475+56.6% | Added |
| BVF Inc | 0 | $0 | 0.00% | −1,508,416−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −707−100.0% | Sold out |